In UK filing, AstraZeneca admits for first time its COVID vaccine can cause rare side effect

AstraZeneca pulls Covid vaccine after admitting rare side effect

The company says the decision is 'commercial' and that the vaccine has been superseded by new inoculations.

AstraZeneca Pulls Covid Vaccine After Admitting Rare Side Effect

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

AstraZeneca's Covid vaccine is being withdrawn worldwide, months after the pharmaceutical giant admitted for the first time in court documents that it can cause a rare and dangerous side effect, the Telegraph reported.

AstraZeneca announces it will stop selling the COVID-19 vaccine in Europe as the drug, originally known as Oxford or Covishield, is not a central part of its business currently. The move comes days after the company declared in an English court that the drug can cause blood clots.

AstraZeneca admits for first time that its Covid vaccine might cause thrombosis

The company's vaccine (later renamed Vaxzevria) was the third to arrive in Spain on 6 February 2021, having been authorised by the European Commission on 29 January 2021

AstraZeneca Admits in Court Documents That COVID-19 Vaccine Could Cause Serious Rare Side Effect

by Misty Severi   British pharmaceutical company AstraZeneca admitted in court documents for the first time that its COVID-19 vaccine could cause a rare blood-clotting side effect. The company is facing accusations that its vaccine contributed to the deaths or impairments of more than 50 people in the United Kingdom whose family are suing the pharmaceutical company. One claimant named Jamie Scott alleged the vaccine caused a permanent brain inju…